Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
Launch of new product range aligns with strategy to diversify into emerging applications with high growth potential
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
Q2 FY25 Total Income was at Rs. 85.4 crore
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
Revolf's infertility and miscarriage tests are a new technology that uses blood tests to detect neoself-antibodies
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
Enhertu demonstrated clinically meaningful efficacy in previously treated patients
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
